A tunable brain-targeted PEGylated ginsenoside Rg1 derivative disrupts the ROS-mediated inflammasome-pyroptosis cascade to ameliorate Alzheimer's cognitive deficits
Biomaterials
· Elsevier
The publisher did not provide an abstract — full text is available via the link below.
Read at publisher →
Citation
A tunable brain-targeted PEGylated ginsenoside Rg1 derivative disrupts the ROS-mediated inflammasome-pyroptosis cascade to ameliorate Alzheimer's cognitive deficits. // Biomaterials. – URL: https://www.sciencedirect.com/science/article/pii/S0142961226007313?dgcid=rss_sd_all
A tunable brain-targeted PEGylated ginsenoside Rg1 derivative disrupts the ROS-mediated inflammasome-pyroptosis cascade to ameliorate Alzheimer's cognitive deficits. Biomaterials. https://www.sciencedirect.com/science/article/pii/S0142961226007313?dgcid=rss_sd_all
“A tunable brain-targeted PEGylated ginsenoside Rg1 derivative disrupts the ROS-mediated inflammasome-pyroptosis cascade to ameliorate Alzheimer's cognitive deficits.” Biomaterials.
@article{article99750,
title = {A tunable brain-targeted PEGylated ginsenoside Rg1 derivative disrupts the ROS-mediated inflammasome-pyroptosis cascade to ameliorate Alzheimer's cognitive deficits},
journal = {Biomaterials},
url = {https://www.sciencedirect.com/science/article/pii/S0142961226007313?dgcid=rss_sd_all}
}